4-(1H-phenanthro[9,10-d]imidazol-2-yl)benzoic acid

ID: ALA4172975

Cas Number: 312507-02-1

PubChem CID: 3122488

Max Phase: Preclinical

Molecular Formula: C22H14N2O2

Molecular Weight: 338.37

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1ccc(-c2nc3c4ccccc4c4ccccc4c3[nH]2)cc1

Standard InChI:  InChI=1S/C22H14N2O2/c25-22(26)14-11-9-13(10-12-14)21-23-19-17-7-3-1-5-15(17)16-6-2-4-8-18(16)20(19)24-21/h1-12H,(H,23,24)(H,25,26)

Standard InChI Key:  PQSLSGIGRIEFOI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 30  0  0  0  0  0  0  0  0999 V2000
    1.5215  -12.0927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5204  -12.9123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2284  -13.3212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9381  -12.9118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9353  -12.0891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2266  -11.6839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6410  -11.6754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3888  -12.0049    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7234  -10.8624    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5220  -10.6894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9290  -11.3957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9258   -9.9863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7370   -9.9860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1406   -9.2844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7340   -8.5826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9197   -8.5869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5198   -9.2891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1496  -10.6897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7400  -11.3918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1432  -12.0956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9559  -12.0983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3636  -11.3915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9581  -10.6906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8124  -13.3203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1050  -12.9112    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8117  -14.1375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8 11  1  0
 10  9  1  0
  9  7  1  0
  5  7  1  0
 10 11  2  0
 11 19  1  0
 18 13  1  0
 12 10  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 12  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 18  2  0
  2 24  1  0
 24 25  2  0
 24 26  1  0
M  END

Alternative Forms

Associated Targets(non-human)

GCN5 Histone acetyltransferase GCN5 (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 338.37Molecular Weight (Monoisotopic): 338.1055AlogP: 5.23#Rotatable Bonds: 2
Polar Surface Area: 65.98Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.71CX Basic pKa: 4.77CX LogP: 3.93CX LogD: 1.73
Aromatic Rings: 5Heavy Atoms: 26QED Weighted: 0.43Np Likeness Score: -0.27

References

1. Xiong H, Han J, Wang J, Lu W, Wang C, Chen Y, Fulin Lian, Zhang N, Liu YC, Zhang C, Ding H, Jiang H, Lu W, Luo C, Zhou B..  (2018)  Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening.,  151  [PMID:29665527] [10.1016/j.ejmech.2018.02.005]

Source